These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 22823461)

  • 1. Structural origin of polymorphism of Alzheimer's amyloid β-fibrils.
    Agopian A; Guo Z
    Biochem J; 2012 Oct; 447(1):43-50. PubMed ID: 22823461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of spin exchange interactions to identify β strand and turn regions in Ure2 prion domain fibrils with site-directed spin labeling.
    Ngo S; Chiang V; Guo Z
    J Struct Biol; 2012 Nov; 180(2):374-81. PubMed ID: 22967940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new structural model of Aβ40 fibrils.
    Bertini I; Gonnelli L; Luchinat C; Mao J; Nesi A
    J Am Chem Soc; 2011 Oct; 133(40):16013-22. PubMed ID: 21882806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
    Singh PK; Maji SK
    Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation.
    McDonough RT; Paranjape G; Gallazzi F; Nichols MR
    Arch Biochem Biophys; 2011 Oct; 514(1-2):27-32. PubMed ID: 21843498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).
    Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK
    Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.
    Sheikh AM; Nagai A
    FEBS J; 2011 Feb; 278(4):634-42. PubMed ID: 21205198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
    Gu L; Guo Z
    J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of introducing a short amyloidogenic sequence from the Aβ peptide at the N-terminus of 18-residue amphipathic helical peptides.
    SivakamaSundari C; Rukmani S; Nagaraj R
    J Pept Sci; 2012 Feb; 18(2):122-8. PubMed ID: 22052825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation at Ser
    Hu ZW; Ma MR; Chen YX; Zhao YF; Qiang W; Li YM
    J Biol Chem; 2017 Feb; 292(7):2611-2623. PubMed ID: 28031462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.
    Petkova AT; Ishii Y; Balbach JJ; Antzutkin ON; Leapman RD; Delaglio F; Tycko R
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16742-7. PubMed ID: 12481027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy.
    Margittai M; Langen R
    Q Rev Biophys; 2008; 41(3-4):265-97. PubMed ID: 19079806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
    Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
    Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
    Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
    Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
    Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
    J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.